S SENSILE MEDICAL
LIVE

Serial Number

79190409

Owner

SENSILE PAT AG

Attorney

Diane B. Melnick

Filing Date

Apr 28, 2016

Add to watchlist:

No watchlists yet
View on USPTO

S SENSILE MEDICAL Trademark

Serial Number: 79190409 • Registration: 5253131

S SENSILE MEDICAL is a trademark filed by SENSILE PAT AG on April 28, 2016. The trademark is classified under Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

SENSILE PAT AG (4 trademarks)

Zugerstrasse 76b

Entity Type: 09

Sensile Medical AG (7 trademarks)

Fabrikstrasse 10

Entity Type: 99

Trademark Details

Filing Date

April 28, 2016

Registration Date

August 1, 2017

Published for Opposition

May 16, 2017

Cancellation Date

February 16, 2024

Goods & Services

Medical services, in particular in the field of care for diabetics; medical testing and analysis for diagnostic or treatment purposes in the fields of diabetes, growth hormone deficiency, pain therapy, and chemotherapy; medical diagnosis of diseases, in particular diabetic diseases; pharmacy advice, namely, pharmaceutical advice; medical and pharmaceutical consultancy, particularly in the field of diabetes; medical equipment rental in the fields of diabetes, growth hormone deficiency, pain therapy, and chemotherapy; medical information, medical advice and medical consultancy, particularly relating to the treatment and care of diabetes; provision of educational information on diabetes via a website; provision of information on the use of medical diagnostic diabetes testing apparatus and consultancy in the field of medical diagnostics via a website

Medical apparatus and instruments, namely, blood glucose meters, devices for measuring glycerin; medical apparatus for analyzing blood and blood plasma; medical apparatus for extracting and analyzing blood; apparatus for diagnoses and for analyses for medical use, in particular glucose meters, devices for measuring blood sugar; medical apparatus for introducing pharmaceutical preparations into the human body, in particular apparatus for introducing insulin and/or glucagon, namely, medical syringes, insulin injectors sold empty, and insulin and glycogen pumps; pumps for medical use, in particular mobile and portable insulin pumps and insulin patch pumps; insulin pumps, diuretic pumps and antibiotic pumps, all for medical use; belts for medical use; injectors for medical use, namely, medical fluid injectors; pens for injecting insulin and glucagon sold empty; brush pens and dispensation devices in the form of pens, sold empty, for accurate, precise dosing and application of medical creams and preparations; medical test kits for diabetes control for clinical or household use

Scientific and technological services and research and design relating thereto, namely, consumer product safety testing in the field of diabetes, growth hormone deficiency, pain therapy, and chemotherapy equipment, scientific research in the field of diabetes, growth hormone deficiency, pain therapy, and chemotherapy, design of diabetes, growth hormone deficiency, pain therapy, and chemotherapy monitoring equipment for others; scientific and technological services and research and design relating thereto, namely, scientific research and new product design services in the field of devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps; technological advice in the field of design and development of technology for devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps; scientific laboratory services; scientific services, namely, conducting of clinical trials for others in the field of diabetes, growth hormone deficiency, pain therapy, and chemotherapy; conducting of clinical trials for others in the field of devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps, all in the field of diabetes, growth hormone deficiency, pain therapy, and chemotherapy; industrial analysis and research services in the field of design of medical equipment for use in the management and treatment of diabetes, growth hormone deficiency, pain therapy, and chemotherapy related medical equipment; industrial analysis and research services in the field of devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps; bacteriological research services; biological research services; design and development of products in the field of fluids, mechanics, electronics and software; technical project study, namely, conducting scientific feasibility studies; research and development of new products for others; technical research services, namely, research in the field of diabetes, growth hormone deficiency, pain therapy, and chemotherapy monitoring technology; carrying out scientific feasibility studies; testing of materials; measuring services, namely, calibration; quality control for others; design and development of software; installation, maintenance and updating and rental of software; software consultancy; all of the foregoing services relating to the fields of diabetes, growth hormone deficiency, pain therapy, and chemotherapy

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Sep 19, 2025 NREP
TOTAL INVALIDATION PROCESSED BY THE IB
Nov 23, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Nov 5, 2024 INTS
INVALIDATION PROCESSED
Nov 5, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 17, 2024 INTR
CANCELLED SECTION 71
Feb 16, 2024 C71T
CHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 1, 2022 ADCH
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 1, 2022 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 1, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 13, 2017 FICS
FINAL DISPOSITION PROCESSED
Nov 13, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 1, 2017 FICR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 26, 2017 ADCH
REGISTERED-PRINCIPAL REGISTER
Aug 1, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 16, 2017 NPUB
PUBLISHED FOR OPPOSITION
May 16, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 26, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 10, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 5, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 5, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 5, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 5, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 5, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 14, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 14, 2017 CRFA
ASSIGNED TO LIE
Mar 13, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 27, 2017 TROA
REFUSAL PROCESSED BY IB
Sep 16, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 29, 2016 RFCS
REFUSAL PROCESSED BY MPU
Aug 29, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 27, 2016 RFCR
NON-FINAL ACTION WRITTEN
Aug 26, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
Aug 23, 2016 MAFR
ASSIGNED TO EXAMINER
Aug 19, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 19, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 18, 2016 REPR